激活的第七因子-抗素复合体,在不同的临床环境中组织因子相关途径的生物标志物:从心血管疾病到癌症的叙述性审查
Sara Moruzzi1, Annalisa Castagna1, Marianna Spizzo1
1Department of Medicine, University of Verona, 37134 Verona, Italy.
Diagnostics (Basel, Switzerland)
|August 29, 2024
概括
组织因子 (TF) 启动血凝并影响各种疾病. 测量激活的因子VII-抗素 (FVIIa-AT) 复合体可能表明TF通路过度激活,并预测癌症等疾病的不良结果.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 病理生理学 病理生理学
背景情况:
- 组织因子 (TF) 是凝血级联的关键发起者和信号蛋白.
- TF通路与血栓形成,感染和瘤性疾病有关.
- 由于其本地化,表达和变体,评估TF活动具有挑战性.
研究的目的:
- 审查关于血FVIIa-AT度在健康和疾病方面的临床研究.
- 评估FVIIa-AT作为功能活性TF的间接生物标志物.
- 探索TF通路激活的预后意义.
主要方法:
- 临床研究的叙述性综述.
- 对血FVIIa-AT度的分析.
- FVIIa-AT水平与临床结果的相关性.
主要成果:
- 高FVIIa-AT度与心血管疾病和癌症的更糟糕结果有关.
- 有证据表明,TF通路过度激活在各种病理中起着不利的作用.
- 数据尚未确定,但表明有预后潜力.
结论:
- 血FVIIa-AT可以作为TF通路活动的有价值的间接生物标志物.
- 升高的FVIIa-AT水平表明在不同的临床环境中具有负面的预后作用.
- 需要进一步的研究来确定FVIIa-AT的最终临床实用性.
相关概念视频
Extrinsic and Intrinsic Pathways of Hemostasis
6.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654
Coagulation
5.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
5.6K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
119
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
119
Clot Retraction and Fibrinolysis
4.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.9K


